Fabrication of versatile targeted lipopolymersomes for improved camptothecin efficacy against colon adenocarcinoma in vitro and in vivo

References

• Jaferian S, Negahdari B, Eatemadi A. Colon cancer targeting using conjugates biomaterial 5-flurouracil. Biomed Pharmacother. 2016;84:780–788.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA: Cancer J Clin. 2020;70(1):7–30.
   PubMed Web of Science ®Google Scholar
• Liska D, Stocchi L, Karagkounis G, et al. Incidence, patterns, and predictors of locoregional recurrence in colon cancer. Ann Surg Oncol. 2017;24(4):1093–1099.
   PubMed Web of Science ®Google Scholar
• Puts MT, Sattar S, McWatters K, et al. Chemotherapy treatment decision-making experiences of older adults with cancer, their family members, oncologists and family physicians: a mixed methods study. Support Care Cancer. 2017;25(3):879–886.
   PubMed Web of Science ®Google Scholar
• Tang Q, Cao B, Cheng G. Co-delivery of small interfering RNA using a camptothecin prodrug as the carrier. ChemComm. 2014;50(11):1323–1325.
   PubMed Web of Science ®Google Scholar
• Alibolandi M, Rezvani R, Farzad SA, et al. Tetrac-conjugated polymersomes for integrin-targeted delivery of camptothecin to colon adenocarcinoma in vitro and in vivo. Int J Pharm. 2017;532(1):581–594.
   PubMedGoogle Scholar
• Ke SZ, Ni XY, Zhang YH, et al. Camptothecin and cisplatin upregulate ABCG2 and MRP2 expression by activating the ATM/NF-κB pathway in lung cancer cells. Int J Oncol. 2013;42(4):1289–1296.
   PubMed Web of Science ®Google Scholar
• Mohammadi M, Taghavi S, Abnous K, et al. Hybrid vesicular drug delivery systems for cancer therapeutics. Adv Funct Mater. 2018;28(36):1802136.
   Web of Science ®Google Scholar
• Bose RJ, Ravikumar R, Karuppagounder V, et al. Lipid–polymer hybrid nanoparticle-mediated therapeutics delivery: advances and challenges. Drug Discovery. 2017;22(8):1258–1265.
   Google Scholar
• Mohammadi M, Alibolandi M, Abnous K, et al. Fabrication of hybrid scaffold based on hydroxyapatite-biodegradable nanofibers incorporated with liposomal formulation of BMP-2 peptide for bone tissue engineering. Nanomedicine. 2018;14(7):1987–1997.
   PubMed Web of Science ®Google Scholar
• Alibolandi M, Abnous K, Mohammadi M, et al. Extensive preclinical investigation of polymersomal formulation of doxorubicin versus Doxil-mimic formulation. J Control Release. 2017;264:228–236.
   PubMed Web of Science ®Google Scholar
• Pang J, Xing H, Sun Y, et al. Non-small cell lung cancer combination therapy: hyaluronic acid modified, epidermal growth factor receptor targeted, pH sensitive lipid-polymer hybrid nanoparticles for the delivery of erlotinib plus bevacizumab. Biomed Pharmacother. 2020;125:109861.
   PubMed Web of Science ®Google Scholar
• Li F, Zhao X, Wang H, et al. Multiple layer‐by‐layer lipid‐polymer hybrid nanoparticles for improved FOLFIRINOX chemotherapy in pancreatic tumor models. Adv Funct. 2015;25(5):788–798.
   Web of Science ®Google Scholar
• Zahiri M, Taghdisi SM, Abnous K, et al. Marriage of phospholipid and block copolymer in lipopolymersome hybrid structure for efficient tumor accumulation. Int J Pharm. 2020;591:120030.
   PubMedGoogle Scholar
• Taghavi S, Abnous K, Babaei M, et al. Synthesis of chimeric polymersomes based on PLA-b-PHPMA and PCL-b-PHPMA for nucleoline guided delivery of SN38. Nanomedicine. 2020;28:102227.
   PubMed Web of Science ®Google Scholar
• Alibolandi M, Alabdollah F, Sadeghi F, et al. Dextran-b-poly (lactide-co-glycolide) polymersome for oral delivery of insulin: in vitro and in vivo evaluation. J Control Release. 2016;227:58–70.
   PubMed Web of Science ®Google Scholar
• Canalle LA, Löwik DW, Van Hest JC. Polypeptide–polymer bioconjugates. Chem Soc Rev. 2010;39(1):329–353.
   PubMed Web of Science ®Google Scholar
• Rideau E, Dimova R, Schwille P, et al. Liposomes and polymersomes: a comparative review towards cell mimicking. Chem Soc Rev. 2018;47(23):8572–8610.
   PubMed Web of Science ®Google Scholar
• Alibolandi M, Ramezani M, Abnous K, et al. Comparative evaluation of polymersome versus micelle structures as vehicles for the controlled release of drugs. J Nanopart Res. 2015;17(2):76.
   Web of Science ®Google Scholar
• Tahir N, Madni A, Correia A, et al. Lipid-polymer hybrid nanoparticles for controlled delivery of hydrophilic and lipophilic doxorubicin for breast cancer therapy. Int J Nanomedicine. 2019;14:4961.
   PubMed Web of Science ®Google Scholar
• Wang G, Wang Z, Li C, et al. RGD peptide-modified, paclitaxel prodrug-based, dual-drugs loaded, and redox-sensitive lipid-polymer nanoparticles for the enhanced lung cancer therapy. Biomed Pharmacother. 2018;106:275–284.
   PubMed Web of Science ®Google Scholar
• Hadinoto K, Sundaresan A, Cheow WS. Lipid–polymer hybrid nanoparticles as a new generation therapeutic delivery platform: eur. J Pharm Biopharm. 2013;85(3):427–443.
   Google Scholar
• Mandal B, Bhattacharjee H, Mittal N, et al. Core–shell-type lipid–polymer hybrid nanoparticles as a drug delivery platform. Nanomedicine. 2013;9(4):474–491.
   PubMed Web of Science ®Google Scholar
• Liu D, Lian Y, Fang Q, et al. Hyaluronic-acid-modified lipid-polymer hybrid nanoparticles as an efficient ocular delivery platform for moxifloxacin hydrochloride. Int J Biol Macromo. 2018;116:1026–1036.
   PubMed Web of Science ®Google Scholar
• Song Y, Cai H, Yin T, et al. Paclitaxel-loaded redox-sensitive nanoparticles based on hyaluronic acid-vitamin E succinate conjugates for improved lung cancer treatment. Int J Nanomedicine. 2018;13:1585.
   PubMed Web of Science ®Google Scholar
• Charbgoo F, Alibolandi M, Taghdisi SM, et al. MUC1 aptamer-targeted DNA micelles for dual tumor therapy using doxorubicin and KLA peptide. Nanomedicine. 2018;14(3):685–697.
   PubMed Web of Science ®Google Scholar
• Alibolandi M, Abnous K, Anvari S, et al. CD133-targeted delivery of self-assembled PEGylated carboxymethylcellulose-SN38 nanoparticles to colorectal cancer. Artif Cells Nanomed Biotechno. 2018;46(sup1):1159–1169.
   PubMed Web of Science ®Google Scholar
• Alibolandi M, Ramezani M, Sadeghi F, et al. Epithelial cell adhesion molecule aptamer conjugated PEG–PLGA nanopolymersomes for targeted delivery of doxorubicin to human breast adenocarcinoma cell line in vitro. Int J Pharm. 2015;479(1):241–251.
   PubMed Web of Science ®Google Scholar
• Wu R, Zhang Z, Wang B, et al. Combination chemotherapy of lung cancer–co-delivery of docetaxel prodrug and cisplatin using aptamer-decorated lipid–polymer hybrid nanoparticles. Drug Des Dev Ther. 2020;14:2249–2261.
   PubMed Web of Science ®Google Scholar
• Cho Y, Lee YB, Lee J-H, et al. Modified AS1411 aptamer suppresses hepatocellular carcinoma by up-regulating galectin-14. PloS One. 2016;11(8):e0160822.
   PubMed Web of Science ®Google Scholar
• Zhang J, Chen R, Fang X, et al. Nucleolin targeting AS1411 aptamer modified pH-sensitive micelles for enhanced delivery and antitumor efficacy of paclitaxel. Nano Res. 2015;8(1):201–218.
   Web of Science ®Google Scholar
• Ghahremani F, Shahbazi-Gahrouei D, Kefayat A, et al. AS1411 aptamer conjugated gold nanoclusters as a targeted radiosensitizer for megavoltage radiation therapy of 4T1 breast cancer cells. RSC Adv. 2018;8(8):4249–4258.
   Web of Science ®Google Scholar
• Kuo T, Lai W, Li C, et al. AS1411 aptamer-conjugated Gd 2 O 3: eu nanoparticles for target-specific computed tomography/magnetic resonance/fluorescence molecular imaging. Nano Res. 2014;7(5):658–669.
   Web of Science ®Google Scholar
• Mosafer J, Mokhtarzadeh A. Cell surface nucleolin as a promising receptor for effective AS1411 aptamer-mediated targeted drug delivery into cancer cells. Curr Drug Deliv. 2018;15(9):1323–1329.
   PubMed Web of Science ®Google Scholar
• Ramezani P, Abnous K, Taghdisi SM, et al. Targeted MMP-2 responsive chimeric polymersomes for therapy against colorectal cancer. Colloids Surf B Biointerfaces. 2020;193:111135.
   PubMed Web of Science ®Google Scholar
• Zavvar T, Babaei M, Abnous K, et al. Synthesis of multimodal polymersomes for targeted drug delivery and MR/fluorescence imaging in metastatic breast cancer model. Int J Pharm. 2020;578:119091.
   PubMedGoogle Scholar
• Alibolandi M, Ramezani M, Abnous K, et al. AS1411 aptamer-decorated biodegradable polyethylene glycol–poly (lactic-co-glycolic acid) nanopolymersomes for the targeted delivery of gemcitabine to non–small cell lung cancer in vitro. J Pharm Sci. 2016;105(5):1741–1750.
   PubMed Web of Science ®Google Scholar
• Li J, Li Q, He M, et al. AS1411 aptamer-modified theranostic liposomes co-encapsulating manganese oxide nano-contrast agent and paclitaxel for MRI and therapy of cancer. RSC Adv. 2019;9(60):34837–34846.
   Web of Science ®Google Scholar
• Arabzadeh S, Tehranizadeh ZA, Haghighi HM, et al. Design, synthesis, and in vitro evaluation of Low Molecular Weight Protamine (LMWP)-based amphiphilic conjugates as gene delivery carriers. AAPS PharmSciTech. 2019;20(3):111.
   PubMed Web of Science ®Google Scholar
• Alibolandi M, Taghdisi SM, Ramezani P, et al. Smart AS1411-aptamer conjugated pegylated PAMAM dendrimer for the superior delivery of camptothecin to colon adenocarcinoma in vitro and in vivo. Int J Pharm. 2017;519(1–2):352–364.
   PubMed Web of Science ®Google Scholar
• Babaei M, Abnous K, Taghdisi SM, et al. Targeted rod-shaped mesoporous silica nanoparticles for the co-delivery of camptothecin and survivin shRNA in to colon adenocarcinoma in vitro and in vivo. Eur J Pharm Biopharm. 2020;156:84–96.
   PubMed Web of Science ®Google Scholar
• Alibolandi M, Abnous K, Hadizadeh F, et al. Dextran-poly lactide-co-glycolide polymersomes decorated with folate-antennae for targeted delivery of docetaxel to breast adenocarcinima in vitro and in vivo. J Control Release. 2016;241:45–56.
   PubMed Web of Science ®Google Scholar
• Arabi L, Badiee A, Mosaffa F, et al. Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin. J Control Release. 2015;220:275–286.
   PubMed Web of Science ®Google Scholar
• Zhu D, Wu S, Hu C, et al. Folate-targeted polymersomes loaded with both paclitaxel and doxorubicin for the combination chemotherapy of hepatocellular carcinoma. Acta Biomater. 2017;58:399–412.
   PubMed Web of Science ®Google Scholar
• Oroojalian F, Babaei M, Taghdisi SM, et al. Encapsulation of thermo-responsive gel in pH-sensitive polymersomes as dual-responsive smart carriers for controlled release of doxorubicin. J Control Release. 2018;288:45–61.
   PubMed Web of Science ®Google Scholar
• Yin Q, Shen J, Zhang Z, et al. Multifunctional nanoparticles improve therapeutic effect for breast cancer by simultaneously antagonizing multiple mechanisms of multidrug resistance. Biomacromolecules. 2013;14(7):2242–2252.
   PubMed Web of Science ®Google Scholar
• Zhang L, He Y, Ma G, et al. Paclitaxel-loaded polymeric micelles based on poly (ɛ-caprolactone)-poly (ethylene glycol)-poly (ɛ-caprolactone) triblock copolymers: in vitro and in vivo evaluation. Nanomedicine. 2012;8(6):925–934.
   PubMed Web of Science ®Google Scholar
• Hilkert SM, Farooq AV, Greenwald MJ. Retinoblastoma: a Global Perspective. Curr Ophthalmol Rep. 2017;5(2):119–127.
   Google Scholar
• Rodriguez-Galindo C, Orbach DB, VanderVeen D. Retinoblastoma. Pediatr Clin. 2015;62(1):201–223.
   PubMed Web of Science ®Google Scholar
• Grossniklaus HE. Retinoblastoma. Fifty years of progress. The LXXI Edward Jackson memorial lecture. Am J Ophthalmo. 2014;158(5):875–891. e1.
   PubMed Web of Science ®Google Scholar
• Natesan S, Sugumaran A, Ponnusamy C, et al. Chitosan stabilized camptothecin nanoemulsions: development, evaluation and biodistribution in preclinical breast cancer animal mode. Int J Biol Macromol. 2017;104:1846–1852.
   PubMed Web of Science ®Google Scholar
• Mohammadi M, Ramezani M, Abnous K, et al. Biocompatible polymersomes-based cancer theranostics: towards multifunctional nanomedicine. Int J Pharm. 2017;519(1–2):287–303.
   PubMedGoogle Scholar
• Wang J, Muhammad N, Li T, et al. Hyaluronic acid-coated camptothecin nanocrystals for targeted drug delivery to enhance anticancer efficacy. Mol Pharm. 2020;17(7):2411–2425.
   PubMedGoogle Scholar
• Zhou Z, Piao Y, Hao L, et al. Acidity-responsive shell-sheddable camptothecin-based nanofibers for carrier-free cancer drug delivery. Nanoscale. 2019;11(34):15907–15916.
   PubMed Web of Science ®Google Scholar
• Laskar P, Somani S, Campbell SJ, et al. Camptothecin-based dendrimersomes for gene delivery and redox-responsive drug delivery to cancer cells. Nanoscale. 2019;11(42):20058–20071.
   PubMed Web of Science ®Google Scholar
• Farokhzad OC. AdvAnces in drug development. Chem Soc Rev. 2012;41(7):2971–3010.
   PubMedGoogle Scholar
• Kneidl B, Peller M, Winter G, et al. Thermosensitive liposomal drug delivery systems: state of the art review. Int J Nanomedicine. 2014;9:4387.
   PubMed Web of Science ®Google Scholar
• Khan S, McCabe J, Hill K, et al. Biodegradable hybrid block copolymer–lipid vesicles as potential drug delivery systems. J Colloid Interface Sci. 2020;562:418–428.
   PubMed Web of Science ®Google Scholar
• Danaei M, Dehghankhold M, Ataei S, et al. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics. 2018;10(2):57.
   PubMed Web of Science ®Google Scholar
• Kawamura J, Kitamura H, Otake Y, et al. Size-controllable and scalable production of liposomes using a v-shaped mixer micro-flow reactor. Org Process Res Dev. 2020;24(10):2122–2127.
   Web of Science ®Google Scholar
• Lin C-H, Al-Suwayeh SA, Hung C-F, et al. Camptothecin-loaded liposomes with α-melanocyte-stimulating hormone enhance cytotoxicity toward and cellular uptake by melanomas: an application of nanomedicine on natural product. J Tradit Complement Med. 2013;3(2):102–109.
   PubMedGoogle Scholar
• Klement G, Baruchel S, Rak J, et al. Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity. T J Clin Investig. 2000;105(8):R15–R24.
   PubMed Web of Science ®Google Scholar
• Khan MM, Madni A, Filipczak N, et al. Folate targeted lipid chitosan hybrid nanoparticles for enhanced anti-tumor efficacy. Nanomedicine. 2020;28:102228.
   PubMed Web of Science ®Google Scholar
• Tahir N, Madni A, Balasubramanian V, et al. Development and optimization of methotrexate-loaded lipid-polymer hybrid nanoparticles for controlled drug delivery applications. Int J Pharm. 2017;533(1):156–168.
   PubMedGoogle Scholar
• Gref R, Lück M, Quellec P, et al. ‘Stealth’corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surf B Biointerfaces. 2000;18(3–4):301–313.
   PubMed Web of Science ®Google Scholar
• Manson J, Kumar D, Meenan BJ, et al. Polyethylene glycol functionalized gold nanoparticles: the influence of capping density on stability in various media. Gold Bull. 2011;44(2):99–105.
   Web of Science ®Google Scholar
• Stebounova LV, Guio E, Grassian VH. Silver nanoparticles in simulated biological media: a study of aggregation, sedimentation, and dissolution. J Nanopart Res. 2011;13(1):233–244.
   Web of Science ®Google Scholar
• Zhang Y, Yang Y, Zhao J, et al. Preparation of ZnO nanoparticles by a surfactant-assisted complex sol–gel method using zinc nitrate. J Sol Gel Sci Techn. 2009;51(2):198–203.
   Web of Science ®Google Scholar
• Ireson CR, Kelland LR. Discovery and development of anticancer aptamers.Mol Cancer Ther. 2006;5(12):2957–2962. [2006].
   PubMed Web of Science ®Google Scholar
• Gaumet M, Vargas A, Gurny R, et al. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters. Eur J Pharm Biopharm. 2008;69(1):1–9.
   PubMed Web of Science ®Google Scholar
• Alibolandi M, Ramezani M, Abnous K, et al. In vitro and in vivo evaluation of therapy targeting epithelial-cell adhesion-molecule aptamers for non-small cell lung cancer. J Control Release. 2015;209:88–100.
   PubMed Web of Science ®Google Scholar
• Taghavi S, Ramezani M, Alibolandi M, et al. Chitosan-modified PLGA nanoparticles tagged with 5TR1 aptamer for in vivo tumor-targeted drug delivery. Cancer Lett. 2017;400:1–8.
   PubMed Web of Science ®Google Scholar
• Bahreyni A, Alibolandi M, Ramezani M, et al. A novel MUC1 aptamer-modified PLGA-epirubicin-PβAE-antimir-21 nanocomplex platform for targeted co-delivery of anticancer agents in vitro and in vivo. Colloids Surf B Biointerfaces. 2019;175:231–238.
   PubMed Web of Science ®Google Scholar
• He C, Hu Y, Yin L, et al. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials. 2010;31(13):3657–3666.
   PubMed Web of Science ®Google Scholar
• Hrkach J, Von Hoff D, Ali MM, et al. Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile. Sci Transl Med. 2012;4(128):128ra39–128ra39.
   PubMed Web of Science ®Google Scholar
• Nejabat M, Soltani F, Alibolandi M, et al. Smac peptide and doxorubicin-encapsulated nanoparticles: design, preparation, computational molecular approach and in vitro studies on cancer cells. J Biomol Struct Dyn. 2020;1–13. 10.1080/07391102.2020.1819420
   PubMed Web of Science ®Google Scholar
• Akbarzadeh M, Babaei M, Abnous K, et al. Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system. Int J Pharm. 2019;570:118645.
   PubMedGoogle Scholar
• Bavi R, Hang Z, Banerjee P, et al. Doxorubicin-conjugated innovative 16-mer DNA aptamer-based Annexin A1 targeted anti-cancer drug delivery. Mol Ther Nucleic. 2020;21:1074–1086.
   Google Scholar